Rainflower Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Daskroi, Gujarat, India, established in 2013.
2013 Daskroi, Gujarat, India Active
Last Updated:
Access Report
About Rainflower Pharmaceuticals Private Limited

Rainflower Pharmaceuticals Private Limited, a active private limited company, was established on 17 October 2013 in Daskroi, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230GJ2013PTC077249. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Mansukhlal Harajibhai Jethva (Director), Jagirbhai Ramnikbhai Parsaniya (Director), Parag Jitendra Kumar Bhatt (Director). Past directors included Ramnikbhai Manjibhai Parsaniya, Karuna Prashant Detroja, Vishal Kantilal Gardhariya. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No B 221, 2Nd Floor Bijal Business Center, Bock B, Aslali Taluka Daskroi, Daskroi, Gujarat, 382427.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2013PTC077249

  • Registration Number

    077249

  • Incorporation Date

    17 October 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.00 M
  • Revenue Growth **** 122.09%
  • Profit Growth **** 100.90%
  • Ebitda **** 102.97%
  • Net Worth 19.37%
  • Total Assets **** 43.79%
Company report

Rainflower Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rainflower Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rainflower Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mansukhlal Harajibhai Jethva Director 30 Jun 2022 Current
Jagirbhai Ramnikbhai Parsaniya Director 30 Jun 2022 Current
Parag Jitendra Kumar Bhatt Director 30 Jun 2022 Current
Kishan Bhupatbhai Trambadiya Director 30 Jun 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jun 2022 Past
Pramod Abcsdd Director 30 Jun 2022 Past
Pramod Abcsdd Director 30 Mar 2016 Past
Pramod Abcsdd Director 30 Mar 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rainflower Pharmaceuticals.

Rainflower Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 122.09% increase. The company also saw a substantial improvement in profitability, with a 100.9% increase in profit. The company's net worth Soared by an impressive increase of 19.37%.

Rainflower Pharmaceuticals revenue growth over time
Rainflower Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 122.09%
*******
*******
*******
*******
Revenue from Operations
*******
 122.08%
*******
*******
*******
*******
Total Assets
*******
 43.79%
*******
*******
*******
*******
Profit or Loss
*******
 100.90%
*******
*******
*******
*******
Net Worth
*******
 19.37%
*******
*******
*******
*******
EBITDA
*******
 102.97%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rainflower Pharmaceuticals?

Unlock access to Rainflower Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
04 Jun 2024 Others ₹1.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Rainflower Pharmaceuticals?

Unlock and access historical data on people associated with Rainflower Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rainflower Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rainflower Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rainflower Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Rainflower Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Rainflower Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 1.00 M with Charge ID 100943214 was registered on 04 Jun 2024. was completed.

  • Director Appointment

    The activity Mansukhlal Harajibhai Jethva was appointed as a Director was appointed as a Director on 30 Jun 2022 & has been associated with this company since 3 years 7 months . was completed.

  • Director Appointment

    Jagirbhai Ramnikbhai Parsaniya was appointed as a Director was appointed as a Director on 30 Jun 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.

  • Director Appointment

    Parag Jitendra Kumar Bhatt was appointed as a Director was appointed as a Director on 30 Jun 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rainflower Pharmaceuticals Private Limited?

The CIN of Rainflower Pharmaceuticals Private Limited is U24230GJ2013PTC077249.

Where is Rainflower Pharmaceuticals Private Limited headquartered?

Rainflower Pharmaceuticals Private Limited is headquartered at Office No B 221, 2Nd Floor Bijal Business Center, Bock B, Aslali Taluka Daskroi, Daskroi, Gujarat, 382427.

When was Rainflower Pharmaceuticals Private Limited incorporated?

Rainflower Pharmaceuticals Private Limited was incorporated on 17 October 2013.

Who are the current directors of Rainflower Pharmaceuticals Private Limited?

The current directors of Rainflower Pharmaceuticals Private Limited are

What is the primary industry of Rainflower Pharmaceuticals Private Limited?

The primary industry of Rainflower Pharmaceuticals Private Limited is Trade.

Is Rainflower Pharmaceuticals Private Limited a listed company?

Rainflower Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rainflower Pharmaceuticals Private Limited?

The authorized capital of Rainflower Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Rainflower Pharmaceuticals Private Limited?

The compliance status of Rainflower Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available